http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 http://www.tapanray.in/drug-data-exclusivity-in-india-innovation-catalyst-or-affordability-risk-for-indian-pharma/?utm_source=rss&utm_medium=rss&utm_campaign=drug-data-exclusivity-in-india-innovation-catalyst-or-affordability-risk-for-indian-pharma http://www.tapanray.in/drug-data-exclusivity-in-india-innovation-catalyst-or-affordability-risk-for-indian-pharma/#comments Sat, 06 Dec 2025 14:33:27 +0000 Tapan Ray http://www.tapanray.in/?p=11008 Continue reading →]]> http://www.tapanray.in/drug-data-exclusivity-in-india-innovation-catalyst-or-affordability-risk-for-indian-pharma/feed/ 0 http://www.tapanray.in/when-patents-meet-patients-why-india-revoked-novartis-vymada-patent/?utm_source=rss&utm_medium=rss&utm_campaign=when-patents-meet-patients-why-india-revoked-novartis-vymada-patent http://www.tapanray.in/when-patents-meet-patients-why-india-revoked-novartis-vymada-patent/#comments Thu, 18 Sep 2025 12:11:29 +0000 Tapan Ray http://www.tapanray.in/?p=10971 Continue reading →]]> http://www.tapanray.in/when-patents-meet-patients-why-india-revoked-novartis-vymada-patent/feed/ 0 http://www.tapanray.in/robust-patents-not-tweaked-monopolies-indias-practical-route-to-affordable-medicines/?utm_source=rss&utm_medium=rss&utm_campaign=robust-patents-not-tweaked-monopolies-indias-practical-route-to-affordable-medicines http://www.tapanray.in/robust-patents-not-tweaked-monopolies-indias-practical-route-to-affordable-medicines/#comments Fri, 30 May 2025 00:00:36 +0000 Tapan Ray http://www.tapanray.in/?p=10902 Continue reading →]]> http://www.tapanray.in/robust-patents-not-tweaked-monopolies-indias-practical-route-to-affordable-medicines/feed/ 0 http://www.tapanray.in/curbing-patent-evergreening-advancing-innovation-and-health-equity-for-a-vikshit-bharat/?utm_source=rss&utm_medium=rss&utm_campaign=curbing-patent-evergreening-advancing-innovation-and-health-equity-for-a-vikshit-bharat http://www.tapanray.in/curbing-patent-evergreening-advancing-innovation-and-health-equity-for-a-vikshit-bharat/#comments Sat, 03 May 2025 07:43:45 +0000 Tapan Ray http://www.tapanray.in/?p=10892 Continue reading →]]> http://www.tapanray.in/curbing-patent-evergreening-advancing-innovation-and-health-equity-for-a-vikshit-bharat/feed/ 0 http://www.tapanray.in/big-pharma-fails-avoiding-drug-price-control-even-in-the-us-why/?utm_source=rss&utm_medium=rss&utm_campaign=big-pharma-fails-avoiding-drug-price-control-even-in-the-us-why http://www.tapanray.in/big-pharma-fails-avoiding-drug-price-control-even-in-the-us-why/#comments Mon, 22 Aug 2022 00:00:49 +0000 Tapan Ray http://www.tapanray.in/?p=10699 Continue reading →]]> http://www.tapanray.in/big-pharma-fails-avoiding-drug-price-control-even-in-the-us-why/feed/ 0 http://www.tapanray.in/to-allay-customers-new-apprehensions-pharma-needs-a-new-conversation/?utm_source=rss&utm_medium=rss&utm_campaign=to-allay-customers-new-apprehensions-pharma-needs-a-new-conversation http://www.tapanray.in/to-allay-customers-new-apprehensions-pharma-needs-a-new-conversation/#comments Mon, 17 May 2021 00:00:10 +0000 Tapan Ray http://www.tapanray.in/?p=10505 Continue reading →]]> http://www.tapanray.in/to-allay-customers-new-apprehensions-pharma-needs-a-new-conversation/feed/ 0 http://www.tapanray.in/impact-of-covid-vaccines-possible-ip-waiver-in-india/?utm_source=rss&utm_medium=rss&utm_campaign=impact-of-covid-vaccines-possible-ip-waiver-in-india http://www.tapanray.in/impact-of-covid-vaccines-possible-ip-waiver-in-india/#comments Mon, 10 May 2021 00:00:39 +0000 Tapan Ray http://www.tapanray.in/?p=10495 Continue reading →]]> http://www.tapanray.in/impact-of-covid-vaccines-possible-ip-waiver-in-india/feed/ 0 http://www.tapanray.in/covid-prompts-pharma-to-move-away-from-competition-driven-business-model/?utm_source=rss&utm_medium=rss&utm_campaign=covid-prompts-pharma-to-move-away-from-competition-driven-business-model http://www.tapanray.in/covid-prompts-pharma-to-move-away-from-competition-driven-business-model/#comments Mon, 26 Oct 2020 00:00:16 +0000 Tapan Ray http://www.tapanray.in/?p=10304 Continue reading →]]> http://www.tapanray.in/covid-prompts-pharma-to-move-away-from-competition-driven-business-model/feed/ 0 http://www.tapanray.in/setting-a-cost-of-time-that-patients-may-gain-from-a-new-therapy/?utm_source=rss&utm_medium=rss&utm_campaign=setting-a-cost-of-time-that-patients-may-gain-from-a-new-therapy http://www.tapanray.in/setting-a-cost-of-time-that-patients-may-gain-from-a-new-therapy/#comments Mon, 16 Mar 2020 00:00:07 +0000 Tapan Ray http://www.tapanray.in/?p=9916 Continue reading →]]> http://www.tapanray.in/setting-a-cost-of-time-that-patients-may-gain-from-a-new-therapy/feed/ 0 http://www.tapanray.in/spirit-behind-drug-patent-grant-secondary-patents-impact-on-drug-access/?utm_source=rss&utm_medium=rss&utm_campaign=spirit-behind-drug-patent-grant-secondary-patents-impact-on-drug-access http://www.tapanray.in/spirit-behind-drug-patent-grant-secondary-patents-impact-on-drug-access/#comments Mon, 09 Sep 2019 00:00:45 +0000 Tapan Ray http://www.tapanray.in/?p=9701 Continue reading →]]> http://www.tapanray.in/spirit-behind-drug-patent-grant-secondary-patents-impact-on-drug-access/feed/ 0